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Background: The transfer of new scientific discoveries into healthcare interventions requires that basic and clinical
researchers work together with health care providers to generate team science. These innovative models require
translational teams, and need to extend beyond the academic environment. The future of translational science
requires partnerships with the healthcare community as well as the broader, general community. This new integrated
model of effective translational teams holds promise for addressing thorny and persistent health disparities, is consistent
with the nation’s strategic priority of eliminating health disparities, and bodes well for increasing healthcare effectiveness
aimed at better health for all.
Discussion: As part of the 13th Research Centers in Minority Institutions (RCMI) International Symposium on
Health Disparities, several senior academic leaders joined efforts to hold a workshop to discuss a model that
considers the incorporation of two translational research strategies in research career development programs:
Comparative effectiveness research (CER) and community-based participatory research (CBPR) for increasing
healthcare effectiveness and eliminating healthcare disparities. Discussion included what issues may be most
germane to the concept of a unified model for research workforce development through formal training and
career development leading to increased effectiveness in healthcare for better health.
Summary: We believe that there is a gap in knowledge and skills in formal research career development
programs that will enable physicians, other clinicians, and basic scientists to actively participate in these two
translational research strategies. The purpose of this paper is to share the outcomes of these discussions, and
encourage further discussion and possible innovation in the formulation of a new model for translational
research workforce development.
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Clinical and translational research is essential to generate
and test interventions to reduce health disparities; how-
ever, health disparities within the United States persist. In
its 2012 report, ‘How Far Have We Come in Reducing
Health Disparities?: Progress since 2000’ [1], the Institute
of Medicine (IOM) noted that health disparities persisted
both across time as well as the lifespan. The IOM also* Correspondence: estela.estape@upr.edu
1School of Health Professions, University of Puerto Rico Medical Sciences
Campus, P.O. Box 365067, San Juan 00936-5067, Puerto Rico
Full list of author information is available at the end of the article
© 2014 Estape et al.; licensee Springer. This is a
Attribution License (http://creativecommons.or
in any medium, provided the original work is pemphasized the importance of the community’s voice in
reducing health disparities.
Support for translational research has increased as many
academic programs now grant degrees in clinical research
requiring achievement of the new translational competen-
cies defined by National Institutes of Health (NIH) for
post-doctoral master level clinical research programs [2].
Collaboration with communities and healthcare systems
has increased as well as the recruitment of basic and
clinical researchers, healthcare providers, and health
professionals. The bidirectional continuum that defines
translational research from basic or bench science (T1),
transitioning through clinical settings (T2), clinical practicen Open Access article distributed under the terms of the Creative Commons
g/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction
roperly credited.
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known [2]. There is a need to understand and support
the development of a practice and community-based
translational research workforce.Methods
The 13th Research Centers for Minority Institutions
(RCMI) International Symposium on Health Disparities
was held in San Juan, Puerto Rico during December
2012. As part of this meeting, the Multidisciplinary
Training and Career Development Key Function (MTCD)
of the Puerto Rico Clinical and Translational Research
Consortium (PRCTRC) and the Hispanic Clinical and
Translational Research Education and Career Development
(HCTRECD) programs collaborated with other academic
leaders from minority institutions within a workshop to
explore: (1) the role of translational research in clinical
research and healthcare, (2) determine if there is a need
for a unified model for research workforce development,
and (3) ascertain if this intervention would increase the
effectiveness of health interventions and reduce health
disparities?
Translational Research Workforce Development, Health-
care Disparities, and Health Disparities are the three critical
elements that were generated. Each will be discussed in
the next section. Comparative effectiveness research
(CER) and community-based participatory research (CBPR)
were selected as two translational research strategies that
have the potential to help transform healthcare and reduce
healthcare disparities.
Translational Research Workforce Development is
the process of training a new generation of researchers
[3]. Proficiency knowledge and skill in conducting
translational research is needed to improve health out-
comes and eliminate health disparities. The conduct of
translational research requires that multiple disciplines
and representatives from different sectors work together
as teams [3]. Team science is expected to result in the
faster transfer of knowledge and other results into
health benefits, while decreasing the economic burden
of health costs.
In translational research, there is an emphasis on decreas-
ing the time it takes to translate discoveries to practice and
healthcare interventions, eliminating the gap that exists
between research and practice, while facilitating research
studies that focus on clinical practice. Academicians have
responded to the lack of qualified investigators with the
development of a curriculum that complies with new
scientific trends and government policies [4]. These cur-
ricula require the skills and competencies that promote
the dissemination and transfer of scientific advances, as
well as the implementation of new paradigms for effective
collaboration and resource sharing.Healthcare disparities
The 2002 Institute of Medicine (IOM) report, ‘Unequal
Treatment: Confronting Racial and Ethnic Disparities in
Health Care’ defined health disparities in healthcare as
racial or ethnic differences in the quality of healthcare
that were not due to access-related factors or clinical
needs, preferences, and appropriateness of intervention
[5]. The bases of these inequities included barriers
within healthcare systems, complex issues related to
patient-provider relationships, and individual challenges
within patients and providers separately. Complex and
bureaucratic systems, such as the US health care delivery
system, are slow to change. The degree to which health
disparities exist often reflect the choices made about the
allocation of resources. As our nation struggles to reign in
the cost of healthcare, health disparities have significant
implications of not only the cost of inadequate care but
the overall quality of healthcare in the US [6]. Research in
health disparities must identify opportunities for appro-
priate interventions, particularly among groups with the
greatest needs.
Comparative Effectiveness Research (CER) has been
defined by the IOM as the “generation and synthesis of
evidence” that compares the benefits and harms of alter-
native ways to improve care delivery or to “prevent,
diagnose, treat, and monitor a clinical condition” [7]. In
other words, by directly comparing existing health care
interventions, we can determine which works best for
which patients, and which poses the greatest benefits,
and harms. The core question of CER is which treatment
works best, for whom, and under what circumstances?
The general importance of CER is reinforced by the evi-
dence that it: (1) provides evidence to inform decisions
and help improve health care; (2) helps decide what forms
of healthcare interventions are best for a problem; and (3)
evaluates which interventions are effective, on average,
across a given patient population.
The inclusion of the community in equitable partner-
ships require sharing power, resources, credit, results and
knowledge, as well as mutually appreciating the unique
strengths that all parties bring to each stage of the project
[8]. These partnerships, of which Community-based Parti-
cipatory Research (CBPR) is an excellent example, should
reflect equity in problem definition, research design, the
actually conducting of the research project, interpreting
the results, and determining how to use results for action.
CBPR begins with a research topic of importance to the
community and has the aim of combining knowledge with
action and achieving social change [9]. CBPR differs from
traditional research in several ways, the most striking
being that it incorporates research, reflection, and action
in a cyclical and iterative process. Unlike traditional
‘research’, CBPR most often seeks understanding through
a cyclical process that combines research processes with
Estape et al. Clinical and Translational Medicine 2014, 3:20 Page 3 of 7
http://www.clintransmed.com/content/3/1/20reflection and action. Because CBPR focuses on issues that
are of importance to the community, social inequities that
often create and/or support health disparities and may
serve as barriers to reducing disparities, are often brought
to light during the process.
Results and discussion
For each of these topics, several questions were developed
and posed to the invited experts; their responses are
based on their perspectives and experiences in clinical
and translational research and translational workforce
development.
Research workforce development
Which elements of translational research are the most
relevant for advancing and improving healthcare prac-
tice? Although the concept of translational research may
have different meanings to each of us according to our
own experience, it is important to note that it has a
common goal: to accelerate the transfer of discovery to
health benefit. For some, translational research is a term
to express the integration of basic sciences and clinical
research (“from bench to bedside”); for others, it means
to accelerate the transfer of new knowledge to practice.
Translational research has been defined in many ways,
including fostering the multidirectional and multidiscip-
linary integration of basic research, patient-oriented
research and population–based research; transforming
scientific discoveries arising from laboratory, clinical
or population studies into clinically relevant applications,
and a process for developing evidence-based interven-
tions and implementing them in practice [10]. As shown
in Figure 1, some of the most relevant academic features
needed for effective translational research education are:
communication, community, technology, mentoring and
entrepreneurship, and all have in common the goal of
improving the health of the public.
Therefore, translational research can be advanced
through many pathways leading to a process by which
knowledge can travel at a faster pace to practice, thus
ensuring that discoveries and innovations reach theFigure 1 Translational research education pathways to eliminate healpatients or populations for whom they are intended.
Taking this in consideration, it’s important to understand:
what are the major benefits of incorporating translational
research with clinical research?
Bringing multiple disciplines and different sectors
with increasing diversity to work together as teams is
expected to:
1. Facilitate a faster transfer of knowledge and scientific
findings into health benefits.
2. Decrease the economic burden of health cost.
3. Eliminate the gap that exists between research and
clinical practice.
4. Facilitate research studies that address the patient
care problems encountered in common clinical
practice.
Thus, we aim for a new health workforce that can
integrate research efficacy with effectiveness. In order to
achieve this aim, what challenges in education have to be
surpassed for an effective integration of translational and
clinical research? Many challenges have been identified,
such as fragmented infrastructure, incompatible databases,
regulatory burden, career disincentives, practice limitations
and lack of funding. There is a strong movement both
in the government and private sector to surpass these
challenges. Academicians are working to respond to these
challenges with the implementation of new paradigms
for effective collaboration and resource sharing [11].
These translational competencies are best achieved in a
multidisciplinary learning and working environment where
leadership, critical thinking and networking skills are
medullar in the education and career development of
this new generation of translational researchers.
Healthcare disparities
Why is it important to study healthcare disparities? Ours
is a society that continues to wrestle with a legacy of
discrimination based on color, educational attainment,
income, gender, ethnicity, and sexual orientation [6].
Facing past and present discrimination poses moral andth disparities.
Estape et al. Clinical and Translational Medicine 2014, 3:20 Page 4 of 7
http://www.clintransmed.com/content/3/1/20ethical issues for healthcare providers and administrators,
particularly in healthcare systems that have supported
unequal distribution of resources. We are also asked to
consider healthcare as a resource tied to social justice,
opportunities, and the quality of life of individuals and
groups (facilitating the advancement of persons eco-
nomically and professionally).
What are some of the contextual and explanatory factors
of racial and ethnic healthcare disparities? A review of
racial and ethnic disparities in access to and use
of medical care reveals clear and disturbing trends of
significant differences in access to and use of medical
care by race and ethnicity within certain disease categories
and types of healthcare services [6]. Factors such as a
patient’s socio-economic status, insurance coverage, health
status, disease severity, availability of needed services,
and patient preferences do not fully explain racial and
ethnic differences in access to medical care. Data indicate
that interpersonal factors (e.g., culture, provider bias,
cultural perceptions and differences, discrimination, and
intentional and unintentional bias) may explain some
causes of healthcare disparities. Least is known about
healthcare system-level characteristics, although these
variables may offer some explanation.
In order to more accurately identify and address those
factors that contribute to healthcare disparities, we must
ask if we can describe some of the general approaches
and strategies for eliminating healthcare disparities and
achieving equitable healthcare. One theoretical model
of healthcare equity [12], as shown in Figure 2, would
require nine factors for success:
1. Continue to increase awareness among providers
and decision makers of the importance of equity in
“achieving best care”.Figure 2 Theoretical model of health equity.2. Insure equitable access to preventive and curative
health care services.
3. Reduce uncertainty in clinical decisions, through
real-time patient medical record and clinical laboratory
information, evidence-based guidelines and
recommended standards of best care.
4. Improve efficiency and coordination of all aspects of
primary care, ambulatory care, specialty care, and
hospital care.
5. Eliminate variations in health care, e.g., due to
unconscious and conscious cost considerations,
reimbursements, and patient insurance coverage or
perceived ability to pay.
6. Increase the knowledge base to better understand
the nature and causes of health care inequities and
appropriate interventions to eliminate them.
7. Create a culturally competent health care system
capable of delivering the highest quality and safest
care available to every patient regardless of race,
ethnicity, social class, culture, ability to pay, or
language proficiency.
8. Insure health system accountability in equitable care
quality by tracking, monitoring and reporting equity
quality measures.
9. Integrate eliminating inequities with quality
improvement processes.
Comparative effectiveness research
The core question of comparative effectiveness research
(CER) is which treatment works best, for which patients,
and under what circumstances? The American Recovery
and Reinvestment Act of 2009 allocated $1.1 billion for
CER [13], which seeks to inform healthcare decisions
by examining evidence on the effectiveness, benefits,
and harms of different treatment options. With this
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more informed treatment decisions that improve health
outcome, taking into account the patient’s preference,
values, and experiences. Its focus on evidence-based com-
parisons of treatment options, together with the joint
decision-making process of patient and provider, makes
CER an effective approach to improving healthcare
outcomes, but also in reducing healthcare costs and
eliminating health disparities.
A factor for consideration in CER is that of treatment
heterogeneity or the heterogeneity of treatment effect
(HTE). Randomized clinical trials (RCTs), considered the
gold standard in clinical research [14], may produce data
indicating that the same treatment may have different
levels of impact of different people although outcomes
may be reported as an average treatment effect (ATE),
implying that treatment outcomes may be similar across
populations with shared (heterogeneous) characteristics.
As CER seeks improved decision-making among patients
and providers, clinicians’ consideration of evidence from
RCTs would include information about treatment varia-
tions within the study populations.
A correlated concept to CER is that of patient-centered
outcomes research (PCOR), which evaluates the outcomes
of healthcare practices, identifying ways that patients may
be more involved with their own healthcare and making
informed decisions about their health outcomes [13]. In
2010, the Patient Protection and Affordable Care Act
(PPACA) established the Patient-Centered Outcomes
Research Institute (PCORI), a national program in CER.
Ultimately, CER and PCOR seek to address the com-
plexity of how clinical treatment options are evaluated
and applied in a multi-dimensional environment that
represents a variety of stakeholders including patients,
providers, healthcare organizations, and insurance compan-
ies, as well as healthcare policy makers. The future of
healthcare and its innovations will require a well-trained
workforce capable of conducting comparative effectiveness
research which will in turn advance translational science.
Community-Based Participatory Research
Community-based participatory research (CBPR) has been
defined as research that is conducted as an equal partner-
ship between traditionally trained “experts” and members
of a community [15]. In CBPR projects, the project begins
with the community and the community participates fully
in all aspects of the research process. This collaborative
approach to research equitably involves all parties in the
research process, recognizing the unique strengths that
each brings to the study. Researchers who choose to
engage in CPBR should ask themselves, ‘Do you believe
that attending to social inequities should be part of a
research agenda?’ Some researchers may be concerned
that addressing social inequities may cloud the researchprocess, thus reducing objectivity and the overall integrity
of the research design. In fact, social inequities must be
addressed as these situations where groups or ‘commu-
nities’ do not have equal social status, social class, and/
or social circles may have created or contribute to a myriad
of health disparities. Unaddressed, these divisions (which
are often economically based), can lead to social divisions
as well as perpetuating discrimination in key issues such as
access to healthcare [6].
The very nature of the CBPR process requires an eco-
logical perspective that examines determinants of health
from more than one ecological level (e.g., individual,
interpersonal, community, organization or policy). By
definition, this would require a more complex research
design requiring objectives at more than one ecological
level. This characteristic of CBPR may require researchers
to ask themselves, ‘Do you question the need to address
health – and therefore your research – from an ecological
perspective?’ The CBPR researcher must be prepared to
understand and navigate the dynamic interrelationships
between and among personal, environmental, social, and
political factors that shape and define ‘community’.
Before entering the field of CBPR, researchers should
ask themselves ‘Do you perceive community participation as
exploitative rather than empowering?’ The definition and
intent of community-based participatory research is often
misinterpreted to be the same as ‘community-oriented’ or
‘community-focused’. These approaches are very different
from CBPR as they do not assume a proactively planned
partnership relationship with community in the research
process. In these models, communities are often used as
‘labs’ where data are collected, analyzed, and reported.
But, there is little change within the community’s health,
social, or economic status at the end of a research project.
Communities in general may be distrustful of ‘outside
experts’. Those with negative experiences where they
believe the community has been exploited by the ‘expert’
are much less likely to open themselves to any partnership
with the research academy. It can be a burden for the
researcher to assure the community that the CBPR
process is not exploitative. And, these assurances must
be validated by actions.
Conclusions
A unified model of training the next generation of clin-
ical and translational research should include: 1) a better
understanding of health disparities and approaches to
achieve health equity, 2) comparative effectiveness research
training to better understand the relative benefits of alter-
native deliveries of healthcare, 3) community participation
in all aspects of research and healthcare decision. What is
the need for a unified model of training for this new
workforce, and how would such a model for workforce
development increase effectiveness in healthcare and
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addressing the challenges of preparing this new generation
of translational research workforce are:
1. Proactive recruitment and inclusion of healthcare
providers in existing academic programs that grant
degrees in translational research. Healthcare
providers, by the nature of their work, are often
unable to attend classes offered in traditional ‘brick
and mortar’ environments. As a result, academic
programs seeking greater participation of healthcare
providers in their degree programs will need to
develop more online offerings as well as other types of
learning strategies such as team facilitation and field
research projects that encourage the cooperative work
between non-clinicians and clinicians as well featuring
more experiential learning opportunities.
2. Develop strategies for teaching how to effectively
engage multiple stakeholders across a variety of
organizations and environments. Healthcare and
community environments feature an array of
stakeholders, each representing unique views,
interests, and needs. Healthcare administrators’
interest in CER may be primarily linked to cost
containment while providers’ interest is likely
grounded in the effectiveness of treatment options
and improved health outcomes. Both views are valid,
given the stakeholders’ role in healthcare. When
proposing a CER study, translational researchers
will need to not only be aware of these differences,
but understand how to work with each so that
well-designed studies can be implemented while
addressing each stakeholders needs.
3. Develop collaborative relationships between
translational researchers within the academy and
stakeholders in healthcare and community. Effective
collaborations are those that reflect full-partnerships
between the academy and the healthcare entity or
community including a willingness to share
decision-making authority, roles in the research
study, and publication recognition. In the same way
that translational researchers are discouraged from
considering communities as ‘research labs’, the same
philosophy applies to healthcare.
In conclusion, clinical and translational research is
seen as a cornerstone in reducing health disparities,
and increasing effectiveness in healthcare for better
health. While the need for research as the T1 and T2
stages of the translational research continuum is not
diminished, as noted by the IOM [1] clinical care within
the healthcare system and the role of communities in
reducing health disparities present clear ‘next steps’ in
the efforts to reduce health disparities.Abbreviations
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